Oral Biofilm Therapeutics Market: By Treatment Options (Antimicrobial Agents, Antiplaque Agents, Nanoparticles, Photodynamic Therapy, Cold Atmospheric Plasma, Herbal/Natural Products, and Others), By End Users (Hospitals and Clinics, Academic Institutes and Research Centers and Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Oral Biofilm Therapeutics Market size was valued at USD 612.4 million in 2023 and is anticipated to grow at a CAGR of 8.2% from 2024-2030. Oral biofilms are complex and dynamic communities of microorganisms that form on various surfaces within the human oral cavity, particularly on teeth and gums. Dental plaque is one of the most commonly forming biofilms in the oral cavity and appears as a slimy layer on the surface of the teeth.

The prevalence of oral diseases plays a pivotal role in driving the growth of the oral biofilm therapy market revenues. Oral diseases, such as dental caries (cavities) and periodontal diseases (gum diseases), implant-related infections, and oropharyngeal candidiasis are closely linked to the formation and persistence of oral biofilms on teeth and gums. As these conditions affect a significant portion of the global population, there is a substantial demand for effective therapeutic solutions to address them. Oral biofilm therapy offers targeted treatments designed to combat the microbial communities within biofilms, preventing and managing oral diseases. Moreover, the growth of the oral biofilm therapy market is significantly driven by the combined forces of growing awareness of oral health and advancements in dental research. Increasing awareness among the general population about the importance of oral hygiene, regular dental check-ups, and the role of oral biofilms in causing dental diseases has spurred demand for effective treatments. Concurrently, ongoing research in dentistry and microbiology has provided deeper insights into the complex nature of oral biofilms and their implications for oral health. These advancements have paved the way for the development of targeted and innovative therapeutic approaches to address oral biofilm-related conditions.

However, developing and gaining regulatory approval for new therapeutic agents can be a lengthy and costly process. Hence stringent regulatory requirements and costly treatment options can limit the growth of the oral biofilm therapy market. Meanwhile, rising healthcare investments can create significant opportunities for market development. Moreover, key market players are announcing innovative launches, strategic collaborations, and several acquisitions to further contribute to the market growth.

 Oral Biofilm Therapeutics Market Developments:        
  • In May 2017, EMS launched its latest AIRFLOW® Prophylaxis Master air polishing system for guided biofilm therapy.

Oral Biofilm Therapeutics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Oral Biofilm Therapy Market Dynamics

The aging population plays a significant role in driving the oral biofilm therapy market further. As individuals age, they become more susceptible to a range of oral health issues, including dental caries, periodontal diseases, and other conditions associated with oral biofilms. This demographic's increased vulnerability to oral diseases underscores the importance of effective oral biofilm therapy to maintain their oral health and overall well-being. Moreover, the globalization of dental care is a significant driver behind the growth of the oral biofilm therapy market. Dental care practices, research, and innovations are increasingly being shared and adopted on a global scale. As dental care becomes more accessible and standardized across different regions, the awareness of oral health issues and the importance of effective treatments for oral biofilm-related conditions expands.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Oral Biofilm Therapeutics Market Segmentation

By Treatment Options
  • Antimicrobial Agents
  • Antiplaque Agents
  • Nanoparticles
  • Photodynamic Therapy
  • Cold Atmospheric Plasma
  • Herbal/Natural Products
  • Others
By End Users
  • Hospitals and Clinics
  • Academic Institutes and Research Centers
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA
  • Rest of MEA

Frequently Asked Questions

The oral biofilm therapy market was valued at USD 612.4 Million in 2023

The oral biofilm therapeutics market key players are: EMS Philips Dentsply Sirona Periogen GC Corporation Waterpik OraVital Inc CURADEN AG Oral-Breeze Sunstar Americas, Inc

The oral biofilm therapeutics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Oral Biofilm Therapeutics Market Introduction 
2.1.Global Oral Biofilm Therapeutics Market  - Taxonomy
2.2.Global Oral Biofilm Therapeutics Market  - Definitions
2.2.1.Treatment Options
2.2.2.End Users
2.2.3.Region
3. Global Oral Biofilm Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID-19 on Market
4. Global Oral Biofilm Therapeutics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Oral Biofilm Therapeutics Market  By Treatment Options, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Antimicrobial Agents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Antiplaque Agents
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Nanoparticles
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Photodynamic Therapy
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Cold Atmospheric Plasma
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Herbal/Natural Products
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6. Global Oral Biofilm Therapeutics Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals and Clinics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Academic Institutes and Research Centers
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Oral Biofilm Therapeutics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Treatment Options Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Antimicrobial Agents
8.1.2.Antiplaque Agents
8.1.3.Nanoparticles
8.1.4.Photodynamic Therapy
8.1.5.Cold Atmospheric Plasma
8.1.6.Herbal/Natural Products
8.1.7.Others
8.2.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals and Clinics
8.2.2.Academic Institutes and Research Centers
8.2.3.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Treatment Options Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Antimicrobial Agents
9.1.2.Antiplaque Agents
9.1.3.Nanoparticles
9.1.4.Photodynamic Therapy
9.1.5.Cold Atmospheric Plasma
9.1.6.Herbal/Natural Products
9.1.7.Others
9.2.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals and Clinics
9.2.2.Academic Institutes and Research Centers
9.2.3.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10.Asia Pacific (APAC) Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Treatment Options Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Antimicrobial Agents
10.1.2.Antiplaque Agents
10.1.3.Nanoparticles
10.1.4.Photodynamic Therapy
10.1.5.Cold Atmospheric Plasma
10.1.6.Herbal/Natural Products
10.1.7.Others
10.2.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals and Clinics
10.2.2.Academic Institutes and Research Centers
10.2.3.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Treatment Options Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Antimicrobial Agents
11.1.2.Antiplaque Agents
11.1.3.Nanoparticles
11.1.4.Photodynamic Therapy
11.1.5.Cold Atmospheric Plasma
11.1.6.Herbal/Natural Products
11.1.7.Others
11.2.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals and Clinics
11.2.2.Academic Institutes and Research Centers
11.2.3.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Oral Biofilm Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Treatment Options Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Antimicrobial Agents
12.1.2.Antiplaque Agents
12.1.3.Nanoparticles
12.1.4.Photodynamic Therapy
12.1.5.Cold Atmospheric Plasma
12.1.6.Herbal/Natural Products
12.1.7.Others
12.2.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals and Clinics
12.2.2.Academic Institutes and Research Centers
12.2.3.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.EMS
13.2.2.Philips
13.2.3.Dentsply Sirona
13.2.4.Periogen
13.2.5.GC Corporation
13.2.6.Waterpik
13.2.7.OraVital Inc
13.2.8.CURADEN AG
13.2.9.Oral-Breeze
13.2.10.Sunstar Americas, Inc
14. Research Methodology 
15. Appendix and Abbreviations 
  • EMS
  • Philips
  • Dentsply Sirona
  • Periogen
  • GC Corporation
  • Waterpik
  • OraVital Inc
  • CURADEN AG
  • Oral-Breeze
  • Sunstar Americas, Inc

Adjacent Markets